Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-000140
Filing Date
2025-02-14
Accepted
2025-02-14 16:30:24
Documents
65
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q nnvc-20241231x10q.htm   iXBRL 10-Q 1419155
2 EX-31.1 nnvc-20241231xex31d1.htm EX-31.1 10982
3 EX-31.2 nnvc-20241231xex31d2.htm EX-31.2 10898
4 EX-32.1 nnvc-20241231xex32d1.htm EX-32.1 6474
5 EX-32.2 nnvc-20241231xex32d2.htm EX-32.2 6645
  Complete submission text file 0001410578-25-000140.txt   5663771

Data Files

Seq Description Document Type Size
6 EX-101.SCH nnvc-20241231.xsd EX-101.SCH 44138
7 EX-101.CAL nnvc-20241231_cal.xml EX-101.CAL 30843
8 EX-101.DEF nnvc-20241231_def.xml EX-101.DEF 198674
9 EX-101.LAB nnvc-20241231_lab.xml EX-101.LAB 338764
10 EX-101.PRE nnvc-20241231_pre.xml EX-101.PRE 260945
68 EXTRACTED XBRL INSTANCE DOCUMENT nnvc-20241231x10q_htm.xml XML 854287
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

EIN.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36081 | Film No.: 25629653
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)